VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,881 | -49.0% | 73,352 | -22.2% | 0.01% | -47.8% |
| Q2 2023 | $621,332 | +86.4% | 94,284 | +92.0% | 0.02% | +64.3% |
| Q1 2023 | $333,389 | -11.1% | 49,100 | -3.3% | 0.01% | -30.0% |
| Q4 2022 | $375,139 | -25.6% | 50,763 | -0.5% | 0.02% | 0.0% |
| Q3 2022 | $504,000 | -14.6% | 51,000 | -5.7% | 0.02% | -20.0% |
| Q2 2022 | $590,000 | -25.4% | 54,100 | +7.4% | 0.02% | -50.0% |
| Q4 2021 | $791,000 | +107.6% | 50,387 | +98.8% | 0.05% | +38.9% |
| Q1 2021 | $381,000 | – | 25,342 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |